title: Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
authors.affiliation: a Department of Experimental Clinical Oncology , Aarhus University Hospital , Denmark.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Hassan Metwally
authors.affiliation: b Oncology Department, Nuclear Medicine , Oncology & Radiotherapy Institute , Islamabad , Pakistan.
authors.forename: Rubina
authors.initials: R
authors.lastname: Ali
authors.affiliation: c Radiation Oncology Center, North Estonia Medical Center , Tallinn , Estonia.
authors.forename: Maire
authors.initials: M
authors.lastname: Kuddu
authors.affiliation: d Radiation Oncology Department, National Cancer Institute , Cairo , Egypt.
authors.forename: Tarek
authors.initials: T
authors.lastname: Shouman
authors.affiliation: e Department of Radiation Oncology , Institute of Oncology , Ljubljana , Slovenia.
authors.forename: Primoz
authors.initials: P
authors.lastname: Strojan
authors.affiliation: a Department of Experimental Clinical Oncology , Aarhus University Hospital , Denmark.
authors.forename: Jens
authors.initials: J
authors.lastname: Overgaard
authors.affiliation: f Department of Oncology , Aarhus University Hospital , Denmark.
authors.forename: Cai
authors.initials: C
authors.lastname: Grau
mesh_terms: D002294:Carcinoma, Squamous Cell; D019583:Dose Fractionation, Radiation; D019983:Guideline Adherence; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008485:Medical Audit; D015337:Multicenter Studies as Topic; D009554:Nimorazole / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012189:Retrospective Studies
chemical_list: D011838:Radiation-Sensitizing Agents; D009554:Nimorazole